Renibus Therapeutics

IN THE PRESS

Lone Star Bio

Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences

April 26, 2024

·

4 min read

Lone Star Bio

Renibus Therapeutics Announces Oral Presentation on RBT-1 at the European Association for Cardio-Thoracic Surgery (EACTS) 2nd Innovation Summit

April 18, 2024

·

4 min read

Lone Star Bio

Renibus Announces Participation at the 23rd Annual Needham Virtual Healthcare Conference

April 2, 2024

·

1 min read

Business

Renibus Announces Leadership Transition

March 21, 2024

·

3 min read

Lone Star Bio

Renibus Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference

February 22, 2024

·

2 min read

Lone Star Bio

Renibus Therapeutics Announces Presentation at Oppenheimer 34th Annual Healthcare Conference

February 7, 2024

·

2 min read

Drug Development

Renibus Announces Publication of Results from Phase 2 Study Evaluating RBT-1 as a Pre-Conditioning Agent to Reduce Post-Operative Complications Following Cardiothoracic Surgery

January 9, 2024

·

5 min read

Drug Development

Renibus Announces First Patient Enrolled in PROTECT Phase 3 Study of RBT-1 to Reduce Post-operative Complications After Cardiothoracic Surgery

October 25, 2023

·

5 min read

Lone Star Bio

Renibus Therapeutics Announces Participation at Upcoming Investor Conferences

October 10, 2023

·

1 min read

JOBS